Company Chairman and CEO Alex Lukianov told the analysts on October 22, while the overall spine market will continue to grow in excess of 10%, NuVasive expects to generate revenue growth in the 30% to 35% range in 2010.
Orthopedics This Week… http://ow.ly/x2y6